This portfolio reflects Lillys strategy of pursuing multiple complementary approaches to metabolic disease: Tirzepatide : Dual GIP/GLP-1 agonist (approved, injectable) Retatrutide : Triple GIP/GLP-1/glucagon agonist (Phase 3, injectable) Orforglipron : Oral GLP-1R agonist (Phase 3, oral) If retatrutide is approved, it could be positioned as a more potent option for patients requiring greater weight loss or those with MASLD, while tirzepatide and orforglipron serve other patient segments
Before enrolling in any telehealth GLP-1 program, consumers should review the platform's privacy policy, telehealth consent materials, and any medical group or technology partner disclosures
Its not yet FDA approved and is only available in clinical research settings
Things are going well, but lately, youve noticed an odd new habit: hiccups
Cannon TD, van Erp TG, Rosso IM, Huttunen M, Lonnqvist J, Pirkola T et al (2002b)
Neurotox Res 2022:127 Wu H et al (2022) Supplementation with selenium attenuates autism-like behaviors and improves oxidative stress, inflammation and related gene expression in an autism disease model
